Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache

Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache

J Scott Andrews,1 David Kudrow,2 Mallikarjuna Rettiganti,1 Tina Oakes,1 Jennifer N Bardos,1 Richard Wenzel,1 Dulanji K Kuruppu,1 Charly Gaul,3 James M Martinez1 1Eli Lilly and Company, Indianapolis, IN, USA; 2California Medical Clinic for Headache, Santa Monica, CA, USA; 3Headache Center, Frankfurt,...

Full description

Bibliographic Details
Main Authors: Andrews JS, Kudrow D, Rettiganti M, Oakes T, Bardos JN, Wenzel R, Kuruppu DK, Gaul C, Martinez JM
Format: Article
Language:English
Published: Dove Medical Press 2021-07-01
Series:Journal of Pain Research
Subjects:
composite pain
frequency
severity
duration
cgrp
Online Access:https://www.dovepress.com/impact-of-galcanezumab-on-total-pain-burden-a-post-hoc-analysis-of-a-p-peer-reviewed-fulltext-article-JPR

Internet

https://www.dovepress.com/impact-of-galcanezumab-on-total-pain-burden-a-post-hoc-analysis-of-a-p-peer-reviewed-fulltext-article-JPR

Similar Items